Life Sciences

Scancell Holdings

Scancell Holdings plc is a biopharmaceutical company focused on the cancer therapeutics market and is developing a pipeline of immunotherapies for the treatment of cancer based on its patented ImmunoBody® and Moditope® platforms. The Company's mission is to develop therapeutic cancer vaccines that stimulate the patient's immune system to mount an active response to 'reject' or kill the growing tumour.

Market: AIM

Ticker: SCLP

www.scancell.co.uk/

Lead analyst: Dr Martin Hall